Analysts See $-0.29 EPS for Exact Sciences (EXAS); Financial Institutions (FISI) Sentiment Is 1.82

February 4, 2018 - By Nellie Frank

Analysts expect Exact Sciences Corporation (NASDAQ:EXAS) to report $-0.29 EPS on February, 20.They anticipate $0.05 EPS change or 14.71% from last quarter’s $-0.34 EPS. After having $-0.23 EPS previously, Exact Sciences Corporation’s analysts see 26.09% EPS growth. The stock decreased 1.21% or $0.6 during the last trading session, reaching $49. About 2.04 million shares traded. Exact Sciences Corporation (NASDAQ:EXAS) has risen 458.24% since February 4, 2017 and is uptrending. It has outperformed by 441.54% the S&P500.

Financial Institutions, Inc. operates as the holding firm for Five Star Bank that provides banking and financial services to individuals, municipalities, and businesses. The company has market cap of $506.28 million. It operates in two divisions, Banking and Non-Banking. It has a 14.93 P/E ratio. The Banking segment includes retail and commercial banking operations.

Among 18 analysts covering EXACT Sciences (NASDAQ:EXAS), 10 have Buy rating, 1 Sell and 7 Hold. Therefore 56% are positive. EXACT Sciences had 64 analyst reports since July 24, 2015 according to SRatingsIntel. As per Friday, December 18, the company rating was initiated by BTIG Research. The firm earned “Buy” rating on Wednesday, May 31 by Benchmark. The company was maintained on Tuesday, October 31 by Leerink Swann. Canaccord Genuity maintained Exact Sciences Corporation (NASDAQ:EXAS) on Tuesday, October 3 with “Buy” rating. Jefferies maintained it with “Buy” rating and $3500 target in Tuesday, July 4 report. The company was maintained on Monday, August 15 by Goldman Sachs. Empire maintained the stock with “Sell” rating in Friday, February 26 report. Cowen & Co maintained the stock with “Buy” rating in Wednesday, May 31 report. The firm earned “Neutral” rating on Thursday, February 25 by Roth Capital. The company was maintained on Tuesday, September 12 by Jefferies.

Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company has market cap of $5.87 billion. The firm develops the Cologuard, a non-invasive stool DNA screening test for the early detection of colorectal cancer and pre-cancer. It currently has negative earnings. It has a collaboration, license, and purchase agreement with Genzyme Corporation; and license agreement with MAYO Foundation for Medical Education and Research.

Since September 1, 2017, it had 0 insider purchases, and 7 sales for $22.47 million activity. Shares for $3.82M were sold by LIDGARD GRAHAM PETER. On Friday, September 29 the insider COWARD D SCOTT sold $1.37M. Another trade for 110,439 shares valued at $5.58 million was sold by Conroy Kevin T.

Investors sentiment decreased to 1.01 in 2017 Q3. Its down 0.26, from 1.27 in 2017Q2. It is negative, as 39 investors sold Exact Sciences Corporation shares while 81 reduced holdings. 44 funds opened positions while 77 raised stakes. 93.65 million shares or 1.18% less from 94.77 million shares in 2017Q2 were reported. Us Bank De reported 730,669 shares. Jpmorgan Chase And Communication invested in 2.87M shares or 0.03% of the stock. Moreover, Gotham Asset Management Lc has 0.23% invested in Exact Sciences Corporation (NASDAQ:EXAS) for 336,919 shares. Hodges holds 398,370 shares. Fisher Asset Mgmt Limited Liability has invested 0% in Exact Sciences Corporation (NASDAQ:EXAS). Fortaleza Asset holds 4,905 shares. Ifc Holding Fl invested in 34,575 shares or 0.11% of the stock. First Tru Advsr Lp has 68,698 shares for 0.01% of their portfolio. Research And Mgmt Company accumulated 1,300 shares or 0.02% of the stock. Price T Rowe Assoc Incorporated Md holds 37,323 shares or 0% of its portfolio. 1,785 are held by Solaris Asset Mngmt Ltd Liability Co. Moreover, California State Teachers Retirement has 0.02% invested in Exact Sciences Corporation (NASDAQ:EXAS). Green Valley Investors Ltd Liability, Delaware-based fund reported 965,350 shares. Raymond James & Associates holds 0.01% or 97,609 shares in its portfolio. Eam Llc owns 63,983 shares.

Canandaigua National Bank & Trust Co holds 2.62% of its portfolio in Financial Institutions, Inc. for 478,183 shares. Alphaone Investment Services Llc owns 125,408 shares or 0.96% of their US portfolio. Moreover, Basswood Capital Management L.L.C. has 0.41% invested in the company for 312,580 shares. The Illinois-based Banc Funds Co Llc has invested 0.32% in the stock. Foundry Partners Llc, a Minnesota-based fund reported 157,315 shares.

Since January 1, 0001, it had 1 insider purchase, and 0 sales for $32,340 activity.

The stock decreased 1.55% or $0.5 during the last trading session, reaching $31.8. About 72,704 shares traded or 27.60% up from the average. Financial Institutions, Inc. (FISI) has risen 13.69% since February 4, 2017 and is uptrending. It has underperformed by 3.01% the S&P500.